KPIs & Operating Metrics(New)
Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios
Asset Utilization RatioAssets AverageEBIT MarginEBITDA MarginEBT MarginEnterprise ValueEquity AverageEquity RatioFCF MarginGross MarginInvested CapitalNet MarginOperating MarginReturn on AssetsReturn on Capital EmployedReturn on EquityReturn on Invested CapitalReturn on Sales

Medpace Holdings (MEDP) Return on Sales (2016 - 2025)

Historic Return on Sales for Medpace Holdings (MEDP) over the last 11 years, with Q4 2025 value amounting to 0.19%.

  • Medpace Holdings' Return on Sales fell 300.0% to 0.19% in Q4 2025 from the same period last year, while for Dec 2025 it was 0.18%, marking a year-over-year decrease of 100.0%. This contributed to the annual value of 0.18% for FY2025, which is 100.0% down from last year.
  • Medpace Holdings' Return on Sales amounted to 0.19% in Q4 2025, which was down 300.0% from 0.17% recorded in Q3 2025.
  • Medpace Holdings' Return on Sales' 5-year high stood at 0.22% during Q4 2024, with a 5-year trough of 0.13% in Q2 2023.
  • Over the past 5 years, Medpace Holdings' median Return on Sales value was 0.17% (recorded in 2023), while the average stood at 0.17%.
  • Per our database at Business Quant, Medpace Holdings' Return on Sales crashed by -300bps in 2021 and then skyrocketed by 600bps in 2024.
  • Medpace Holdings' Return on Sales (Quarter) stood at 0.16% in 2021, then increased by 7bps to 0.17% in 2022, then dropped by -10bps to 0.16% in 2023, then soared by 39bps to 0.22% in 2024, then decreased by -13bps to 0.19% in 2025.
  • Its Return on Sales was 0.19% in Q4 2025, compared to 0.17% in Q3 2025 and 0.15% in Q2 2025.